Curriculum Vitae

Prof. Dr. Klaus Lieb
Chair
Department of Psychiatry and Psychotherapy University Medical Center Mainz
Untere Zahlbacherstr. 8
D-55131 Mainz
phone +49/6131/17-7335
fax +49/6131/229974
klaus.lieb@unimedizin-mainz.de

Positions and functions

Curriculum vitae

1985-1992 Studies of Medicine and Philosophy at the Universities of Ulm, Tübingen and Los Angeles, USA. Degree in Human Medicine at the University of Ulm, Germany

1992 Dr. med., M.D.

1992-1994 Doctor in training and Research assistant at the Departments of Internal Medicine and Anatomy and Cell Biology at the University of Ulm, Germany

1994-1999 Research assistant and junior doctor at the Department of Psychiatry and Psychotherapy as well as Neurology at the University Medical Centre Freiburg, Germany

1999 Habilitation and „Venia legendi“ in Psychiatry at the Faculty of Medicine in Freiburg, Germany

2001-2007 Vice Chair at the Department of Psychiatry and Psychotherapy, University Medical Centre Freiburg, Germany

Since 2007 Director and Chair, Department of Psychiatry and Psychotherapy, University Medical Centre Mainz, Germany

2018-2020  Managing director of German Resilience Centre (DRZ)

Since 2020  Scientific director of the Leibniz Institute for Resilience Research (LIR)

Scientific focuses

Research Awards

  • Hormosan-Forschungspreis Psychiatrie 2003
  • Golden Helix Award 2004
  • Hochschullehrer des Jahres 2013 (Deutscher Hochschulverband)
  • Hamburger Prize Personality Disorders 2013

Scientific publications

For full references see „pubmed“ (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi), search for „Lieb K not Lieb KP“. 

Current h-Index: 72 (Web of Science), 98 (GoogleScholar)

Selected publications

  • Schäfer SK, von Boros L, Schaubruch LM, Kunzler AM, Lindner S, Koehler F, Werner T, Zappalà F, Helmreich I, Wessa M, Lieb K, Tüscher O. (2024): Digital interventions to promote psychological resilience: a systematic review and meta-analysis. NPJ Digit Med. 7(1):30.
  • Schäfer SK, Thomas LM, Lindner S, Lieb K. (2023): World Health Organization's low-intensity psychosocial interventions: a systematic review and meta-analysis of the effects of Problem Management Plus and Step-by-Step. World Psychiatry. 22(3):449-462
  • Schäfer SK, Kunzler AM, Kalisch R, Tüscher O, Lieb K. (2022): Trajectories of resilience and mental distress to global major disruptions. Trends Cogn Sci. 26(12):1171-1189
  • Engelmann J, Zillich L, Frank J, Wagner S, Cetin M, Herzog DP, Müller MB, Tadic A, Foo JC, Sirignano L, Braus DF, Dahmen N, Sordon S, Riemenschneider M, Spaniol C, Gasparoni G, Rietschel M, Witt SH, Lieb K, Streit F. (2022): Epigenetic signatures in antidepressant treatment response: a methylome-wide association study in the EMC trial. Transl Psychiatry. 12(1):268.
  • Bohus M, Stoffers-Winterling J, Sharp C, Krause-Utz A, Schmahl C, Lieb K (2021): Borderline personality disorder. Lancet 398(10310):1528-1540. 
  • Koch C, Schleeff J, Techen F, Wollschläger D, Schott G, Kölbel R, Lieb K (2020): Impact of physicians' participation in non-interventional post-marketing studies on their prescription habits: A retrospective 2-armed cohort study in Germany. PLoS Med 17(6):e1003151. doi: 10.1371/journal.pmed.1003151. 
  • Storebø OJ, Stoffers-Winterling JM, Völlm BA, Kongerslev MT, Mattivi JT, Jørgensen MS, Faltinsen E, Todorovac A, Sales CP, Callesen HE, Lieb K, Simonsen E: Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2020 May 4;5(5):CD012955. doi: 10.1002/14651858.CD012955.pub2.
  • Chmitorz A, Kunzler A, Helmreich I, Tüscher O, Kalisch R, Kubiak T, Wessa M, Lieb K: Intervention studies to foster resilience - A systematic review and proposal for a resilience framework in future intervention studies. Clin Psychol Rev 59,78–100. (2018). doi: 10.1016/j.cpr.2017.11.002
  • Tadić A, Wachtlin D, Berger M, Braus DF, van Calker D, Dahmen N, Dreimüller N, Engel A, Gorbulev S, Helmreich I, Kaiser A, Kronfeld K, Schlicht KF, Tüscher O, Wagner S, Hiemke C, Lieb K: Randomized controlled study of early medication change for non-improvers to antidepressant therapy in major depression – The EMC trial. Eur Neuropsychopharmacol 26(4),705–716. (2016). doi: 10.1016/jeuroneuro.2016.02.003
  • Tadic A, Müller-Engling L, Schlicht KF, Kotsiari A, Dreimüller N, Kleimann A, Bleich S, Lieb K, Frieling H: Methylation of the promotor of brain-derived neurotrophic factor exon IV and antidepressant response in major depression. Mol Psychiatry 19,281–283. (2014). doi: 10.1038/mp.2013.58
  • Lieb K, Völlm B, Rücker G, Timmer A, Stoffers JM: Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials. Br J Psychiatry 2010;196(1):4-12. doi: 10.1192/bjp.bp.108.062984 
  • Rüsch N, Lieb K, Göttler I, Hermann C, Schramm E, Richter H, Jacob GA, Corrigan P, Bohus M: Shame and implicit self-concept in women with borderline personality disorder. Am J Psychiatry 164,500–508. (2007). doi: 10.1176/ajp.2007.164.3.500
  • Lieb K, Brucker S, Bach M, Els T, Lücking CH, Greenlee MW: Impairment in preattentive visual processing in patients with Parkinson`s disease. Brain 122,303–313. (1999). doi: 10.1093/brain/122.2.303


Selected books

  • K. Lieb, B. Heßlinger, N. Dreimüller, G. Jacob: 50 Fälle Psychiatrie und Psychotherapie. Elsevier - Urban & Fischer, 6. Auflage, 2020
  • K. Lieb, Klemperer D, Kölbel R, Ludwig WD (Hrsg.): Interessenkonflikte, Korruption und Compliance im Gesundheitswesen. Medizinisch Wissenschaftliche Verlagsgesellschaft, 1. Auflage (2018)
  • K. Lieb (Hrsg.): Intensivkurs Psychiatrie und Psychotherapie. Elsevier - Urban & Fischer, München, 10. Auflage, 2023

Conflict of interest statement

  • A statement of conflicts of interests of Prof. Dr. K. Lieb is presented here.